RE-CELLULARIZATION VIA ELECTROPORATION THERAPY (RECET) COMBINED WITH GLP-1RA TO REPLACE INSULIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES 6 MONTHS RESULTS OF THE EMINENT STUDY

被引:0
|
作者
Busch, Celine [1 ]
Meiring, Suzanne [1 ]
Van Baar, Annieke [1 ]
Holleman, Frits [1 ]
Nieuwdorp, Max [1 ]
Bergman, Jacques [1 ]
机构
[1] Amsterdam UMC Locatie AMC, Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1272
引用
收藏
页码:AB760 / AB760
页数:1
相关论文
共 50 条
  • [1] Electroporation therapy (ReCET) of the duodenum combined with GLP-1RA to replace insulin in type 2 diabetes patients: 12 months results from the first-in-human study
    Busch, C. B. E.
    Meiring, S.
    van Baar, A. C. G.
    Holleman, F.
    Nieuwdorp, M.
    Bergman, J. J. G.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S55 - S55
  • [2] Duodenal Recellularization via Electroporation Therapy (ReCET) and GLP-1 RA to Replace Insulin in T2D Patients-EMINENT Study Six-Month Results
    Busch, Celine B. E.
    Meiring, Suzanne
    Van Baar, Annieke C. G.
    Holleman, Frits
    Nieuwdorp, Max
    Bergman, Jacques J.
    DIABETES, 2023, 72
  • [3] DURABLE EFFECTS OF DUODENAL ABLATION USING ELECTROPORATION COMBINED WITH SEMAGLUTIDE TO ELIMINATE INSULIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES; 18 MONTHS RESULTS OF THE EMINENT STUDY
    Busch, Celine
    Meiring, Suzanne
    Van Baar, Annieke
    Holleman, Frits
    Nieuwdorp, Max
    Bergman, Jacques
    GASTROINTESTINAL ENDOSCOPY, 2024, 99 (06) : AB739 - AB739
  • [4] Real-World Glycemic Control from GLP-1RA Therapy with and Without Concurrent Insulin in Patients with Type 2 Diabetes
    Singhal, Mukul
    Unni, Sudhir
    Schauerhamer, Marisa
    Nguyen, Hiep
    Hurd, Jeff
    McAdam-Marx, Carrie
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (03): : 267 - 275
  • [5] Eliminating exogenous insulin therapy in patients with type 2 diabetes by duodenal ablation and GLP-1RA decreases risk scores for cardiovascular events
    Meiring, S.
    Busch, C. B. E.
    van Baar, A. C. G.
    Hemke, R.
    Holleman, F.
    Nieuwdorp, M.
    Bergman, J. J. G. H. M.
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [6] Eliminating exogenous insulin therapy in patients with type 2 diabetes by duodenal ablation and GLP-1RA decreases risk scores for cardiovascular events
    S. Meiring
    C. B. E. Busch
    A. C. G. van Baar
    R. Hemke
    F. Holleman
    M. Nieuwdorp
    J. J. G. H. M. Bergman
    Cardiovascular Diabetology, 21
  • [7] The efficacy and safety of combined GLP-1RA and basal insulin therapy among inadequately controlled T2D with premixed insulin therapy
    Liu, Jhih-Syuan
    Su, Sheng-Chiang
    Kuo, Feng-Chih
    Li, Peng-Fei
    Huang, Chia-Luen
    Ho, Li-Ju
    Chen, Kuan-Chan
    Liu, Yi-Chen
    Lin, Chih-Ping
    Cheng, An-Che
    Lee, Chien-Hsing
    Lin, Fu-Huang
    Hung, Yi-Jen
    Liu, Hsin-Ya
    Lu, Chieh-Hua
    Hsieh, Chang-Hsun
    MEDICINE, 2023, 102 (10) : E33167
  • [8] Efficacy and safety of IDegLira (combination of insulin degludec plus liraglutide), in insulin-naive patients with type 2 diabetes uncontrolled on GLP-1 receptor agonist (GLP-1RA) therapy
    Linjawi, S.
    Bode, B. W.
    Chaykin, L. B.
    Courreges, J. -P.
    Handelsman, Y.
    Lehmann, L. M.
    Mishra, A.
    Simpson, R. W.
    DIABETOLOGIA, 2015, 58 : S401 - S402
  • [9] Outcomes of SGLT-2i and GLP-1RA Therapy Among Patients With Type 2 Diabetes and Varying NAFLD Status
    Bea, Sungho
    Jeong, Han Eol
    Filion, Kristian B.
    Yu, Oriana H. Y.
    Cho, Young Min
    Lee, Bon Hyang
    Chang, Yoosoo
    Byrne, Christopher D.
    Shin, Ju-Young
    JAMA NETWORK OPEN, 2023, 6 (12) : E2349856
  • [10] GLP-1RA therapy increases circulating vascular regenerative cell content in people living with type 2 diabetes
    Park, Brady
    Krishnaraj, Aishwarya
    Teoh, Hwee
    Bakbak, Ehab
    Dennis, Fallon
    Quan, Adrian
    Hess, David A.
    Verma, Subodh
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2024, 327 (02): : H370 - H376